SCHEMBL23569409

SCHEMBL23569409

Cc1c(S(=O)(=O)Cl)csc1Cl

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
TRPV4 Q9HBA0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23531733 0.81 KDM4E (0.38) KDM4EGAA
Hydrochloric Acid SCHEMBL27326477 0.79 KDM4E (0.34) KDM4EGAA
SCHEMBL23569067 0.78 KDM4E (0.33) KDM4EGAA
SCHEMBL3037140 0.77 KDM4E (0.31) KDM4EGAATRPV4
SCHEMBL6286677 0.74
SCHEMBL4093857 0.72 ALDH1A1 (0.41) KDM4EGAA
SCHEMBL11486082 0.69 DAO (0.34) KDM4EGAA
SCHEMBL23569214 0.68
SCHEMBL13621104 0.66
SCHEMBL12709169 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021123237-A1 2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE Oxford Drug Design Limited (GB) 2021-06-24 WO disclosed